These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 12671031
21. Comparison of statins in hypertriglyceridemia. Stein EA, Lane M, Laskarzewski P. Am J Cardiol; 1998 Feb 26; 81(4A):66B-69B. PubMed ID: 9526817 [Abstract] [Full Text] [Related]
23. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Meyer E, Westerveld HT, de Ruyter-Meijstek FC, van Greevenbroek MM, Rienks R, van Rijn HJ, Erkelens DW, de Bruin TW. Atherosclerosis; 1996 Aug 02; 124(2):221-35. PubMed ID: 8830935 [Abstract] [Full Text] [Related]
24. Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins. Ishigami M, Yamashita S, Sakai N, Hirano K, Hiraoka H, Nakamura T, Matsuzawa Y. Atherosclerosis; 2003 Jun 02; 168(2):359-66. PubMed ID: 12801620 [Abstract] [Full Text] [Related]
25. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models. Krause BR, Newton RS. Atherosclerosis; 1995 Oct 02; 117(2):237-44. PubMed ID: 8801869 [Abstract] [Full Text] [Related]
26. Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia. Castro Cabezas M, Verseyden C, Meijssen S, Jansen H, Erkelens DW. J Clin Endocrinol Metab; 2004 Dec 02; 89(12):5972-80. PubMed ID: 15579746 [Abstract] [Full Text] [Related]
31. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia. Nordøy A, Hansen JB, Brox J, Svensson B. Nutr Metab Cardiovasc Dis; 2001 Feb 02; 11(1):7-16. PubMed ID: 11383326 [Abstract] [Full Text] [Related]
36. The effect of atorvastatin on serum lipoproteins in acromegaly. Mishra M, Durrington P, Mackness M, Siddals KW, Kaushal K, Davies R, Gibson M, Ray DW. Clin Endocrinol (Oxf); 2005 Jun 02; 62(6):650-5. PubMed ID: 15943824 [Abstract] [Full Text] [Related]
37. A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group. McKenney JM, McCormick LS, Weiss S, Koren M, Kafonek S, Black DM. Am J Med; 1998 Feb 02; 104(2):137-43. PubMed ID: 9528731 [Abstract] [Full Text] [Related]
38. Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia. Guan Y, Hou X, Tian P, Ren L, Tang Y, Song A, Zhao J, Gao L, Song G. Front Endocrinol (Lausanne); 2021 Feb 02; 12():646185. PubMed ID: 33967959 [Abstract] [Full Text] [Related]
39. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia. Frost RJ, Otto C, Geiss HC, Schwandt P, Parhofer KG. Am J Cardiol; 2001 Jan 01; 87(1):44-8. PubMed ID: 11137832 [Abstract] [Full Text] [Related]